Prior Authorization Updates

(1)

Managed Health Services (MHS) requires prior authorization as a condition of payment for many services. This Notice contains information regarding such prior authorization requirements and is applicable to all products offered by MHS, with changes effective July 1, 2014.

Refer to the Frequently Asked Questions below for guidance regarding how to obtain prior authorizations from MHS.

1. Quantitative Testing for Drugs of Abuse & Genetic/Molecular Diagnostic Testing

Laboratory providers have experienced a high number of claim denials for both Quantitative Testing for Drugs of

Abuse and Genetic/Molecular Diagnostic Testing due to lack of prior authorization by the ordering provider. MHS will

be requiring laboratory providers to contact ordering providers to verify that a prior authorization number has been obtained for these services. It is the ordering provider’s responsibility to request prior authorization for Quantitative Testing for Drugs of Abuse and Genetic/Molecular Diagnostic Testing services.

2. Specialized Radiation Therapy

MHS will be requiring ordering providers to obtain prior authorization for prior authorization for services categorized as Radiation Oncology. It is the ordering provider’s responsibility to request prior authorization for Intensity Modulation Radiation Therapy, Proton and Neutron Beam Therapy, and Stereotactic Radiotherapy.

3. Durable Medical Equipment

MHS is making updates to our 2014 authorization requirements. Please reference the attached list or visit the provider portal at mhsindiana.com to review HCPC codes that will require authorization for MHS contracted and non-contracted providers.

FREQUENTLY ASKED QUESTIONS How do I determine if a specific service requires prior authorization?

 You may determine which specific codes require prior authorization by visiting our Prior Auth PreScreen tool at mhsindiana.com. Just enter the CPT or HCPC code and the PreScreen Tool will advise you whether the service requires prior authorization.

 Additionally, enclosed is a spreadsheet which also lists the updated codes in these categories which require prior authorization.

How do I request a prior authorization for these services?

 You may submit the prior authorization request by faxing an authorization to 1-866-912-4245. The fax authorization form can be found on our website at mhsindiana.com.

 You may call MHS Medical Management at 1-877-647-4848.

 You may submit the prior authorization request utilizing our Secure Web Portal at mhsindiana.com. If your request is approved, you will receive verification through the Secure Web Portal. If you are not currently registered on our Secure Web Portal, you may register through a quick and simple process.

What information will I be required to submit in connection with the prior authorization request?  CPT or HCPC code

 Diagnosis Code

 Name, Tax ID number, and NPI number for both the requesting and servicing providers

 Medical records to substantiate the need for the service

If you have any questions regarding this information, you may contact Provider Services at 1-877-647-4848 or contact your dedicated Provider Relations Specialist. You may request an electronic copy of the attached code set via the MHS website using the “Contact Us” or “Secure Messaging” functions.

(2)

 Non-highlighted codes are codes that will require prior authorization as of July 1, 2014. 1. Quantitative Testing for Drugs of Abuse & Genetic/Molecular Diagnostic Testing

Quantitative Testing for Drugs of Abuse

CPT CODE DESCRIPTION

80154 DRUG SCREEN QUANTITATIVE BENZODIAZEPINES

80184 DRUG SCREEN QUANTITATIVE PHENOBARBITAL

82145 AMPHETAMINE OR METHAMPHETAMINE, CHEMICAL, QUANTITATIVE

82205 BARBITURATES; QUANTITATIVE

82520 COCAINE, QUANTITATIVE

82646 DIHYDROCODEINONE

82649 DIHYDROMORPHINONE, QUANTITATIVE

83805 MEPROBAMATE, BLOOD OR URINE

83840 METHADONE

83887 NICOTINE 83925 ASSAY OF OPIATES

83992 PHENCYCLIDINE (PCP)

Genetic/Molecular Diagnostic Testing

CPT CODE DESCRIPTION

81161 DMD DUPLICATION/DELETION ANALYSIS

81200 ASPA GENE

81201 APC GENE ANALYSIS FULL GENE SEQUENCE

81202 APC GENE ANALYSIS KNOWN FAMILIAL VARIANTS

81203 APC GENE ANALYSIS DUPLICATION/DELETION VARIANTS

81205 BCKDHB GENE

81206 BCR/ABL1 GENE MAJOR BP 81207 BCR/ABL1 GENE MINOR BP 81208 BCR/ABL1 GENE OTHER BP

81209 BLM GENE

81210 BRAF GENE

81211 BRCA1&2 SEQ & COM DUP/DEL 81212 BRCA1&2 185&5385&6174 VAR 81213 BRCA1&2 UNCOM DUP/DEL VAR 81214 BRCA1 FULL SEQ & COM DUP/DEL

81215 BRCA1 GENE KNOWN FAM VARIANT

(3)

81217 BRCA2 GENE KNOWN FAM VARIANT

81220 CFTR GENE COM VARIANTS

81221 CFTR GENE KNOWN FAM VARIANTS

81222 CFTR GENE DUP/DELET VARIANTS

81223 CFTR GENE FULL SEQUENCE

81224 CFTR GENE INTRON POLY T 81225 CYP2C19 GENE COM VARIANTS

81226 CYP2D6 GENE COM VARIANTS

81227 CYP2C9 GENE COM VARIANTS

81228 CYTOGEN MICRARRAY COPY NMBR

81229 CYTOGEN M ARRAY COPY NO&SNP

81235 EGFR GENE ANALYSIS COMMON VARIANTS

81240 F2 GENE 81241 F5 GENE 81242 FANCC GENE 81243 FMR1 GENE DETECTION 81244 FMR1 GENE CHARACTERIZATION 81245 FLT3 GENE 81250 G6PC GENE 81251 GBA GENE

81252 GJB2 GENE ANALYSIS FULL GENE SEQUENCE 81253 GJB2 GENE ANALYSIS KNOWN FAMILIAL VARIANTS

81254 GJB6 GENE ANALYSIS COMMON VARIANTS

81255 HEXA GENE

81256 HFE GENE

81257 HBA1/HBA2 GENE

81260 IKBKAP GENE

81261 IGH GENE REARRANGE AMP METH

81262 IGH GENE REARRANG DIR PROBE 81263 IGH VARI REGIONAL MUTATION

81264 IGK REARRANGEABN CLONAL POP

81265 STR MARKERS SPECIMEN ANAL

81266 STR MARKERS SPEC ANAL ADDL

81267 CHIMERISM ANAL NO CELL SELEC 81268 CHIMERISM ANAL W/CELL SELECT

(4)

81275 KRAS GENE

81280 LONG QT SYND GENE FULL SEQ

81281 LONG QT SYND KNOWN FAM VAR

81282 LONG QT SYN GENE DUP/DLT VAR

81287 MGMT (O-6-methylguanine-DNA methyltransferase) (eg, glioblastoma multiforme), methylation analysis

81290 MCOLN1 GENE

81291 MTHFR GENE

81292 MLH1 GENE FULL SEQ

81293 MLH1 GENE KNOWN VARIANTS

81294 MLH1 GENE DUP/DELETE VARIANT 81295 MSH2 GENE FULL SEQ

81296 MSH2 GENE KNOWN VARIANTS

81297 MSH2 GENE DUP/DELETE VARIANT 81298 MSH6 GENE FULL SEQ

81299 MSH6 GENE KNOWN VARIANTS

81300 MSH6 GENE DUP/DELETE VARIANT

81301 MICROSATELLITE INSTABILITY

81302 MECP2 GENE FULL SEQ

81303 MECP2 GENE KNOWN VARIANT

81304 MECP2 GENE DUP/DELET VARIANT

81310 NPM1 GENE

81315 PML/RARALPHA COM BREAKPOINTS

81316 PML/RARALPHA 1 BREAKPOINT 81317 PMS2 GENE FULL SEQ ANALYSIS 81318 PMS2 KNOWN FAMILIAL VARIANTS 81319 PMS2 GENE DUP/DELET VARIANTS

81321 PTEN GENE ANALYSIS FULL SEQUENCE ANALYSIS 81322 PTEN GENE ANALYSIS KNOWN FAMILIAL VARIANT

81323 PTEN GENE ANALYSIS DUPLICATION/DELETION VARIANT 81324 PMP22 GENE ANAL DUPLICATION/DELETION ANALYSIS 81325 PMP22 GENE ANALYSIS FULL SEQUENCE ANALYSIS 81326 PMP22 GENE ANALYSIS KNOWN FAMILIAL VARIANT

81330 SMPD1 GENE COMMON VARIANTS

81331 SNRPN/UBE3A GENE

81332 SERPINA1 GENE

(5)

81341 TRB@ GENE REARRANGE DIRPROBE

81342 TRG GENE REARRANGEMENT ANAL

81350 UGT1A1 GENE

81355 VKORC1 GENE

81370 HLA I & II TYPING LR 81371 HLA I & II TYPE VERIFY LR 81372 HLA I TYPING COMPLETE LR 81373 HLA I TYPING 1 LOCUS LR 81374 HLA I TYPING 1 ANTIGEN LR 81375 HLA II TYPING AG EQUIV LR 81376 HLA II TYPING 1 LOCUS LR 81377 HLA II TYPE 1 AG EQUIV LR 81378 HLA I & II TYPING HR

81379 HLA I TYPING COMPLETE HR 81380 HLA I TYPING 1 LOCUS HR 81381 HLA I TYPING 1 ALLELE HR 81382 HLA II TYPING 1 LOC HR 81383 HLA II TYPING 1 ALLELE HR

81400 MOPATH PROCEDURE LEVEL 1

81479 UNLISTED MOLELCULAR PATHOLOGY PROCEDURE

81500 ONCO (OVARIAN) BIOCHEMICAL ASSAY TWO PROTEINS 81503 ONCO (OVARIAN) BIOCHEMICAL ASSAY FIVE PROTEINS 81504

ONCOLOGY (TISSUE OF ORIGIN), MICROARRAY GENE EXPRESSION PROFILING OF > 2000 GENES, UTILIZING FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUE, ALGORITHM REPORTED AS TISSUE SIMILARITY SCORES

81506 ENDOCRINOLOGY BIOCHEMICAL ASSAY SEVEN ANAL

81507

FETAL ANEUPLOIDY (TRISOMY 21, 18, AND 13) DNA SEQUENCE ANALYSIS OF SELECTED REGIONS USING MATERNAL PLASMA, ALGORITHM REPORTED AS A RISK SCORE FOR EACH TRISOMY

(6)

81509 FETAL CONGENITAL ABNOR ASSAY 3 PROTEINS 81510 FETAL CONGENITAL ABNOR ASSAY THREE ANAL 81511 FETAL CONGENITAL ABNOR ASSAY FOUR ANAL 81512 FETAL CONGENITAL ABNOR ASSAY FIVE ANAL

81599 UNLISTED MULTIANALYTE ASSAY ALGORITHMIC ANALYSIS

83890 MOLECULE ISOLATE

83891 MOLECULE ISOLATE NUCLEIC

83892 MOLECULAR DIAGNOSTICS

83893 MOLECULE DOT/SLOT/BLOT

83894 MOLECULE GEL ELECTROPHOR

83896 MOLECULAR DX; NUCLEIC ACID PROBE EA

83897 MOLECULE NUCLEIC TRANSFER

83898 MOLECULAR DX AMPLIFICATION TARGET EA SEQUENCE 83900 MOLECULAR DX AMP TARGET MULTIPLEX 1ST 2 SEQ 83901 MOLECULAR DX AMP TARGET MULTIPLEX EA ADDL SEQ 83902 MOLECULAR DX; REVERSE TRANSCRIPTION

83903 MOLEC DX; MUTATION SCAN BY PHYS PROP-1 SEGMT EA 83904 MOLEC DX; MUTATION ID-SEQUENCING-1 SGMT EA 83905 MOLEC DX; MUTATION ID-ALLELE SPEC TRANSCRIP-1-EA 83906 MOLEC DX; MUTATION ID-ALLELE SPEC TRANSLAT-1-EA 83907 LYSE CELLS FOR NUCLEIC EXT

83908 MOLECULAR DX AMPLIFICATION SIGNAL EA SEQUENCE 83909 NUCLEIC ACID HIGH RESOLUTE

83912 MOLECULAR DX; INTERPT & REPORT 83913 RNA STABILIZATION

83914 MUTATION ID ENZYMATIC LIG/PRIMER XTN 1 SGM EA 83915 NUCLEOTIDASE 5'-

86812 TISSUE TYPING; HLA TYPING, A, B, OR C (EG, A10, B7, B27), SINGLE ANTIGEN 86813 TISSUE TYPING; HLA TYPING, A, B, AND/OR C (EG, A10, B7, B27), MULTIPLE A 86816 TISSUE TYPING; HLA TYPING, DR/DQ, SINGLE ANTIGEN

86817 TISSUE TYPING; HLA TYPING, DR/DQ, MULTIPLE ANTIGENS 86821 TISSUE TYPING; LYMPHOCYTE CULTURE, MIXED(MLC) 86822 TISSUE TYPING; LYMPHOCYTE CULTURE, PRIMED(PLC) 86825 HLA X-MATCH, NON-CYTOTOXIC

86826 HLA X-MATCH, NON-CYT ADD-ON 86828 HLA CLASS I&II ANTIBODY QUAL

(7)

86829 HLA CLASS I/II ANTIBODY QUAL 86830 HLA CLASS I PHENOTYPE QUAL 86831 HLA CLASS II PHENOTYPE QUAL 86832 HLA CLASS I HIGH DEFIN QUAL 86833 HLA CLASS II HIGH DEFIN QUAL 86834 HLA CLASS I SEMIQUANT PANEL 86835 HLA CLASS II SEMIQUANT PANEL

88230 TISS CULTURE NON-NEOPLAS DISORD; LYMPHOCYTE 88233 TISS CULTURE NON-NEOPLAS DISORD; SKIN/SOLID TISS 88235 TISS CULTURE NON-NEOPLAS DISORD; AMNIOTIC FLUID 88237 TISS CULTURE NEOPLAS DISORD; MARROW/BLD CELLS 88239 TISS CULTURE NEOPLAS DISORD; SOLID TUMOR

88240 CRYOPRESERV-FREEZE & STORE CELLS EA CELL LINE 88241 THAWING & EXPANSION FROZEN CELLS EA ALIQUOT 88245 CHROMOSOME ANALY BREAK SYNDROM; SCE 20-25 CELLS

88248 CHROMOSOME ANALY; BASELINE BREAKAGE

88249 CHROMOSOME ANALY BREAK SYNDROM; CLASTOGEN STRESS

88261 CHROMO ANALY; CT 5 CELLS 1 KARYOTYPE W/BANDING 88262 CHROMO ANALY; CT 15-20 CELLS 2 KARYOTYPES W/BAND 88263 CHROMO ANALY; CT 45 CEL MOSAICISM 2 KARYO W/BAND 88264 CHROMOSOME ANALY; ANALY 20-25 CELLS

88267 CHROMO ANALY AMNIO FLUID CT 15 CELLS 1 KARYOTYPE 88269 CHROMO ANALY AMNIO FLUID CELLS CT 6-12 COLONIES 88271 MOLEC CYTOGEN; DNA PROBE EA

88272 MOLEC CYTOGEN; CHROMOSOM IN SITU HYBRID 3-5 CELL 88273 MOLEC CYTOGEN; CHROMOSOM HYBRID 10-30 CELLS 88274 MOLEC CYTOGEN; INTERPHASE IN SITU HYBRID 25-99 88275 MOLEC CYTOGEN; INTERPHASE IN SITU HYBRID 100-300

88280 CHROMOSOME ANALY; ADD KARYOTYPES EA STUDY

88283 CHROMOSOME ANALY; ADD SPECIALIZED BANDING TECH 88285 CHROMOSOME ANALY; ADD CELLS COUNTED EA STUDY 88289 CHROMOSOME ANALY; ADD HIGH RESOLUTION STUDY 88291 CYTOGEN & MOLEC CYTOGEN INTERPT & REPORT 88299 UNLISTED CYTOGENETIC STUDY

88384 RA-BASED EVAL MLT MOLEC PRBS 11 THRU 50 PRBS 88385 RA-BASED EVAL MLT MOLEC PRBS 51 THRU 250 PRBS

(8)

88386 RA-BASED EVAL MLT MOLEC PRBS 251 THRU 500 PRBS S3713 KRAS MUTATION ANALYSIS

S3800 GENETIC TESTING FOR AMYOTROPHIC LATERAL SCLEROSIS (ALS) S3818 COMPLETE GENE SEQUENCE ANALYSIS

S3819 COMPLETE GENE SEQUENCE ANALYSIS

S3820 COMPLETED BRCA1 AND BRCA2 GENE SEQUENCE ANALYSIS FOR SUSCEP S3822 SINGLE MUTATION ANALYSIS FOR SUSCE TO BREAST AND OVARION CANCER

S3823 3-MUTATION ANALYSIS FOR SUSCEP/BREAST &OVARION CANCER IN ASHKENAZI INDI S3828 COMPLETE GENE SEQUENCE ANALYSIS, MLH1 GENE

S3829 COMPLETE GENE SEQUENCE ANALYSIS, MLH2 GENE S3830 COMPLETE MLH1 AND MLH2 GENE SEQUENCE ANALYSIS S3831 SINGLE MUTATION ANALYSIS

S3833 COMPLETE APC GENE SEQUENCE ANAL/SUSCEPTIBILITY TO (FAP)

S3834 SINGLE-MUTATION ANALYSIS /SUSCEPTIBILITY TO (FAP)&ATTENUATED FAP S3835 COMPLETE GENE SEQUENCE ANALYSIS FOR CYSTIC FIBROSIS GENETIC TESTING S3837 COMPLETE GENE SEQUENCE ANALYSIS FOR HEMOCHROMATOSIS GENETIC TESTING S3840 DNA ANALYSIS FOR GERMLINE MUTATIONS OF THE RET PROTO-ONCOGENE

S3841 GENETIC TESTING FOR RETINOBLASTOMA

S3842 GENETIC TESTING FOR VON HIPPEL-LINDAU DISEASE

S3843 DNA ANALYSIS OF THE F5 GENE FOR SUSCEP TO FACTOR V LEIDEN THROMBOPHILIA S3844 DNA ANLYSS/CONNEXIN 26 GENE (GJB2)/SUSCEP/CONGENITAL, PRFND DEAFNESS S3845 GENETIC TESTING FOR ALPHA-THALASSEMIA

S3846 GENETCI TESTING FOR HEMOGLOBIN E BETA-THALASSEMIA S3847 GENETIC TESTING FOR TAY-SACHS DISEASE

S3848 GENETIC TESTING FOR GAUCHER DISEASE S3849 GENETIC TESTING FOR NIEMANN-PICK DISEASE S3850 GENETIC TESTING FOR SICKLE CELL ANEMIA S3851 GENETIC TESTING FOR CANAVAN DISEASE

S3852 DNA ANLYS/APOE EPILSON 4 ALLELE FOR SUSCEP ALZHEIMER'S DISEASE S3853 GENETIC TESTING FOR MYOTONIC MUSCULAR DYSTROPHY

(9)

Specialized Radiation Therapy CPT

CODE CODE DESCRIPTION

61796 Stereotactic radiosurgery (SRS) (particle beam, gamma ray, or linear accelerator); 1 simple cranial lesion

61797 SRS; each additional cranial lesion, simple 61798 SRS; 1 complex cranial lesion

61799 SRS; each additional cranial lesion, complex 63620 SRS; 1 spinal lesion

63621 SRS; each additional spinal lesion

77301 Intensity modulated radiotherapy (IMRT) plan, including dose-volume histograms for target and critical structure partial tolerance specifications

77338 Multi-leaf collimator (MLC) device(s) for IMRT, design and construction per IMRT plan 77371 Radiation treatment delivery, SRS, complete course of treatment of cranial lesion(s)

consisting of 1 session; multi-source cobalt 60 based

77372 Radiation treatment delivery, SRS, complete course of treatment of cranial lesion(s) consisting of 1 session; linear accelerator based

77373 Stereotactic body radiation therapy (SBRT), treatment delivery, per fraction to 1 or more lesions, including image guidance, entire course not to exceed 5 fractions

77418 Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session

77422 High energy neutron radiation treatment delivery; single treatment area using a single port or parallel-opposed ports with no blocks or simple blocking.

77423 High energy neutron radiation treatment delivery; 1 or more isocenter(s) with coplanar or non-coplanar geometry with blocking and/or wedge, and/or compensator(s)

77432 Stereotactic radiation treatment management of cranial lesion(s) (complete course of treatment consisting of one session)

77435 SBRT, treatment management, per treatment course, to one or more lesions, including image guidance, entire course not to exceed 5 fractions

77520 Proton treatment; simple, without compensation 77522 Proton treatment delivery; simple, with compensation 77523 Proton treatment delivery; intermediate

77525 Proton treatment delivery; complex

0073T

Compensator-based beam modulation treatment delivery of inverse planned treatment using 3 or more high resolution (milled or cast) compensator convergent beam modulated fields, per treatment session

(10)

G0251

Linear accelerator based SRS, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, maximum five sessions per course of treatment

G0339 Image-guided robotic linear accelerator-based SRS, complete course of therapy in one session or first session of fractionated treatment

G0340

Image-guided robotic linear accelerator-based SRS, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatment

3. Durable Medical Equipment CPT CODE CODE DESCRIPTION

A6501 _{COMPRS BURN GARMNT BDYSUIT CSTM FAB}

A6503 _{COMPRS BRN GARMNT FCE HOOD CSTM FAB}

A6507 COMPRS BRN GARMNT FT KNEE LEN CSTM

A6511 COMPRS BRN GARMNT LW TRNK LEG OPN

A8003 _{HELMET PROTECTIVE HARD CUSTOM FABR INCL ALL COMPONENTS/ACCESSOR} B4224 _{PARENTERAL NUTRITION ADMIN KIT PER DAY}

E0147 WALKER, HEAVY DUTY, MULTIPLE BRAKING SYSTEM, VARIABLE WHEEL RSISTANCE

E0371 NONPWR ADV PRESS REDUC MATRS OVERLAY STAN L/W E0372 _{PWR AIR MATRS OVERLAY STAN MATRS LENGTH/WIDTH}

E0373 _{NONPWR ADV PRESS REDUC MATRS}

E0575 NEBULIZER ULTRASONIC

E0585 NEBULIZER W/COMPRESSOR & HEATER E0604 _{BREAST PUMP HEAVY DUTY HOSPITAL GRADE} E0617 _{EXT DEFIB W/INTEGRATED ECG ANALY}

E0618 APNEA MONITOR W/O RECORDING FEATURE

E0619 APNEA MONITOR W/RECORDING FEATURE

E0781 _{AMBULATORY INFUSION PUMP 1/MULTI CHAN PT WEARS} E0782 _{INFUS PUMP IMPL NON-PROGMMABLE}

E0783 INFUS PUMP SYST IMPLNT PROGRAMABLE (INCL COMPON) E0786 IMPLNT PROGRAM INFUS PUMP REPLCMT

E0791 _{PARENTERAL INFUSION PUMP STATIONARY 1/MULTICHANL} E1050 _{FULL RECLINE WHEELCHAIR FIX ARM DETACHABLE LEGS} E1405 OXYGEN & WATER VAPOR ENRICH W/HEATED DELIVERY E1406 OXYGEN & WATER VAPOR ENRICH WO HEATED DELIVERY E1600 _{DELIVERY/INSTALL CHARGES RENAL DIALYSIS EQUIP} E1610 _{REVERSE OSMOSIS WATER PURIFICATION SYSTEM} E1615 DEIONIZER WATER PURIFICATION SYSTEM

(11)

E1801 _{SPS ELBOW DEVICE}

E1802 DYN ADJUSTBL FORARM PRON/SUPIN DEVC E1805 _{DYN ADJUS WRIST EXTENSION/FLEXION DEVICE} E1810 _{DYN ADJUS KNEE EXTENSION/FLEXION DEVICE} E1811 _{SPS KNEE DEVICE}

E1815 DYN ADJUS ANKLE EXTENSION/FLEXION DEVICE E1816 _{SPS ANKLE DEVICE}

E1818 _{SPS FOREARM DEVICE}

E1825 _{DYN ADJUS FINGER EXTEN/FLEXION DEVICE} E1830 DYN ADJUS TOE EXTENSION/FLEXION DEVICE E1840 _{DYNAMIC ADJUSTABLE SHOULDER FLEXION}

E1841 _{MXIDIR STATIC PROGS STRETCH SHLDR DEVC INCL CUFF}

E2000 _{GASTRIC SUCTION PUMP, HOME MODEL, PORTABLE OR STATIONARY, ELECTRIC} E2100 BLOOD GLUCOSE MONITOR WITH INTEGRATED VOICE SYNTHESIZER

E2120 _{PULSE GNRTR SYS/TYMPANIC TRTMNT OF INNER EAR ENDOLYMPHATIC FLUID}

E2227 _{GEAR REDUCTION DRIVE WHEEL}

E2228 _{MWC ACC WHEELCHAIR BRAKE}

E2402 NEG PRESSURE WOUND THERAPY ELECTRICAL PUMP, STATIONARY OR PORTABLE

E2626 _{SEO MOBILE ARM SUP ATT TO WC} E2627 _{ARM SUPP ATT TO WC RANCHO TY} E2628 _{MOBILE ARM SUPPORTS RECLININ} E2629 FRICTION DAMPENING ARM SUPP

E2630 _{MONOSUSPENSION ARM/HAND SUPP}

K0730 _{CONTROLLED DOSE INHALATION DRUG DELIVERY SYSTEM}

L0430 _{DEWALL POSTURE PROTECTOR}

L0632 LSO SAG RIGID FRAME CUST L0700 _{SPINAL-CERVICAL-THORACIC-} L3330 _{LIFT, ELEVATION, METAL EX} L5973 _{ANK-FOOT SYS DORS-PLANT F}

L6709 TERM DEV MECH HAND VOL CLOSE

L7181 _{ELECTRONIC ELBO SIMULTANEOUS}

L8619 _{REPLACE COCHLEAR PROCESSOR}

Q0479 _{POWER MODULE COMBO VAD, R}

Q0480 DRIVER PNEUMATIC VAD, REP Q0481 _{MICROPRCSR CU ELEC VAD, REP}

Q0482 _{MICROPRCSR CU COMBO VAD, REP}

Q0483 _{MONITOR ELEC VAD, REP}

Q0484 MONITOR ELEC OR COMB VAD REP

(12)

Q0491 _{EMR PWR SOURCE COMBO VAD REP}

Q0495 CHARGER ELEC/COMBO VAD, REP

Q0496 _{BATTERY ELEC/COMBO VAD, REP}

Q0502 _{MOBILITY CART PNEUM VAD, REP}

Q0503 _{BATTERY PNEUM VAD REPLACEMNT}

Q0504 PWR ADPT PNEUM VAD, REP VEH Q0506 _{LITH-ION BATT ELEC/PNEUM}

Q1003 _{NTIOL CATEGORY 3}

Q4100 _{SKIN SUBSTITUTE, NOS}

Q4114 INTEGRA FLOWABLE WOUND MA

Q4118 _{MATRISTEM MICROMATRIX}